2cureX AB (publ) (2CUREX.ST)

SEK 0.35

(4.19%)

Inventory Summary of 2cureX AB (publ)

  • 2cureX AB (publ)'s latest annual inventory in 2023 was -1000.00 SEK , down 0.0% from previous year.
  • 2cureX AB (publ)'s latest quarterly inventory in 2024 Q1 was - SEK , up 100.0% from previous quarter.
  • 2cureX AB (publ) reported annual inventory of - SEK in 2022, down 0.0% from previous year.
  • 2cureX AB (publ) reported annual inventory of - SEK in 2021, down 0.0% from previous year.
  • 2cureX AB (publ) reported quarterly inventory of - SEK for 2024 Q2, down 0.0% from previous quarter.
  • 2cureX AB (publ) reported quarterly inventory of - SEK for 2023 Q1, down 0.0% from previous quarter.

Annual Inventory Chart of 2cureX AB (publ) (2023 - 2015)

Historical Annual Inventory of 2cureX AB (publ) (2023 - 2015)

Year Inventory Inventory Growth
2023 -1000.00 SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 100.0%
2018 -2.47 Million SEK -20.17%
2017 -2.06 Million SEK 13.72%
2016 -2.38 Million SEK 51.12%
2015 -4.88 Million SEK 0.0%

Peer Inventory Comparison of 2cureX AB (publ)

Name Inventory Inventory Difference
Calliditas Therapeutics AB (publ) 20.42 Million SEK 100.005%
AcouSort AB (publ) 2.08 Million SEK 100.048%
Active Biotech AB (publ) -2500.00 SEK 60.0%
Alzinova AB (publ) -3.27 Million SEK 99.969%
Amniotics AB (publ) 534 Thousand SEK 100.187%
Asarina Pharma AB (publ) - SEK Infinity%
BioArctic AB (publ) - SEK Infinity%
Camurus AB (publ) 100.95 Million SEK 100.001%
Cantargia AB (publ) - SEK Infinity%
Scandinavian ChemoTech AB (publ) 4.03 Million SEK 100.025%
Elicera Therapeutics AB (publ) -446.98 Thousand SEK 99.776%
Genovis AB (publ.) 14.9 Million SEK 100.007%
Guard Therapeutics International AB (publ) -1486.00 SEK 32.705%
Mendus AB (publ) - SEK Infinity%
Kancera AB (publ) -1950.00 SEK 48.718%
Karolinska Development AB (publ) - SEK Infinity%
LIDDS AB (publ) - SEK Infinity%
Lipum AB (publ) - SEK Infinity%
Lipigon Pharmaceuticals AB (publ) -1.62 Million SEK 99.938%
Magle Chemoswed Holding AB (publ) 35.22 Million SEK 100.003%
Modus Therapeutics Holding AB (publ) - SEK Infinity%
NextCell Pharma AB 545.23 Thousand SEK 100.183%
OncoZenge AB (publ) -862.99 Thousand SEK 99.884%
Saniona AB (publ) 1.00 SEK 100100.0%
Simris Alg AB (publ) 1.09 Million SEK 100.092%
Vicore Pharma Holding AB (publ) - SEK Infinity%
Xbrane Biopharma AB (publ) 106.85 Million SEK 100.001%
Xintela AB (publ) 398 Thousand SEK 100.251%
Ziccum AB (publ) -4.18 Million SEK 99.976%
Isofol Medical AB (publ) - SEK Infinity%
Xspray Pharma AB (publ) 43.78 Million SEK 100.002%
CombiGene AB (publ) -1.79 Million SEK 99.944%
Diamyd Medical AB (publ) 24.05 Million SEK 100.004%
Intervacc AB (publ) 10.48 Million SEK 100.01%
Alligator Bioscience AB (publ) 2.00 SEK 50100.0%
Sprint Bioscience AB (publ) -7.13 Million SEK 99.986%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK Infinity%
Corline Biomedical AB -3.85 Million SEK 99.974%
IRLAB Therapeutics AB (publ) 1000.00 SEK 200.0%
Bio-Works Technologies AB (publ) 9.06 Million SEK 100.011%
Aptahem AB (publ) - SEK Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK Infinity%
Fluicell AB (publ) 3.15 Million SEK 100.032%
Biovica International AB (publ) 2.19 Million SEK 100.045%
Spago Nanomedical AB (publ) 1.00 SEK 100100.0%
Abliva AB (publ) - SEK Infinity%
Egetis Therapeutics AB (publ) 700 Thousand SEK 100.143%
I-Tech AB 4.28 Million SEK 100.023%
Hansa Biopharma AB (publ) 9.79 Million SEK 100.01%
Cyxone AB (publ) - SEK Infinity%
ExpreS2ion Biotech Holding AB (publ) - SEK Infinity%
Biosergen AB -4.92 Million SEK 99.98%
Nanologica AB (publ) 2.97 Million SEK 100.034%
SynAct Pharma AB - SEK Infinity%
Annexin Pharmaceuticals AB (publ) - SEK Infinity%
BioInvent International AB (publ) 11.84 Million SEK 100.008%
Stayble Therapeutics AB (publ) -321.14 Thousand SEK 99.689%
Oncopeptides AB (publ) 2.42 Million SEK 100.041%
Pila Pharma AB (publ) 1.00 SEK 100100.0%
Ascelia Pharma AB (publ) - SEK Infinity%
Diagonal Bio AB (publ) 1.02 Million SEK 100.097%